Here are five highlights.
1. The analysts predict the sales could land between $106.9 million and $108.4 million for the first quarter.
2. In the first quarter of 2017, Orthofix saw sales of $102.74 million, reflecting a 4.8 percent year-over-year growth between 2017 and 2018.
3. Zacks anticipates Orthofix will report full-year sales of $456.1 million.
4. Full-year sales could range between and $453.5 million and $460 million.
5. Orthofix will officially report its earnings results May 3.
More articles on devices:
Xtant Medical forms new partnership to extend medical device access: 3 insights
15 spine devices receive FDA 510(k) clearance in March 2018
1st spine surgery with SpineGuard’s PediGuard performed in China — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
